Masimo Corporation announced its third quarter 2024 financial results on November 5, 2024, reporting consolidated revenue of $504.6 million, an increase of 5.4% compared to the third quarter of 2023. Healthcare revenue contributed $343.3 million to this total.
The company reported non-GAAP diluted earnings per share of $0.98, surpassing analyst estimates. This strong performance was driven by the core healthcare segment, which demonstrated consistent growth.
Masimo also updated its full-year 2024 guidance, increasing its non-GAAP operating margin and EPS projections. The full-year non-GAAP EPS guidance was raised to a range of $3.95 to $4.10, up from the prior estimate of $3.80 to $4.00, reflecting confidence in ongoing operational improvements.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.